Hottest IPO of the Year: Giving Legs To Previously Disabled

If you are looking for success in medical devices, ReWalk (RWLK) would be a good one to emulate.  Today, ReWalk executives rang the opening bell at Nasdaq.  Business press has crowned them Hottest IPO of the Year.  This year, they were named the New England Innovation of the Year.

In case your missed it: Marlborough, MA—June 26, 2014 — Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.

Here’s our first look:

Dr. Amit Goffer, who founded the company in 2001, was inspired to develop the ReWalk exoskeleton unit because of his own personal story. Dr. Goffer is quadriplegicand his goal was to develop a product that would enable persons with spinal cord injuries to walk again. Over the past decade, Argo has grown from a small research and development start-up based in Israel to an international company with headquarters in the US, Germany and Israel.

ReWalk Personal, designed for everyday use by individuals at home and in their communities, is currently under review for FDA Clearance and is already being used in Europe and other parts of the world. It is custom-fit for each user, and this revolutionary cutting-edge technology allows users to stand, turn, and walk indoors and outdoors on a daily basis.

The ReWalk Rehabilitation unit is used in the clinical rehabilitation environment, and provides a training base for users before obtaining their personal unit, while offering valuable means of exercise and therapy for individuals with lower limb disabilities.

Argo Medical Technologies, the team behind the ReWalk™ exoskeleton system, has been named 2014 New England Innovation of the Year in the SBANE 2014 New England Innovation Awards Gala for its outstanding innovation and entrepreneurship.

“It is an honor to receive this recognition from SBANE,” said Larry Jasinski, CEO of Argo Medical Technologies. “We are incredibly proud of the work and revolutionary technologies being developed at ReWalk. It is thrilling to see the burgeoning market of exoskeleton systems included among such a prestigious group of innovations.”

The ReWalk System is the most tested and has the most published data of any other exoskeleton, and there are more people using the ReWalk than all other exoskeleton systems combined.

Today, September 17, 2014 ReWalk executives rang the opening bell at Nasdaq.

ReWalk at NASDAQ Opening Bell